Clinical trial
Experimental Medication For the Treatment of Generalized Anxiety Disorder
NCT00097708 · Jazz Pharmaceuticals, Industry · Completed
Key facts
| NCT number | NCT00097708 |
|---|---|
| Title | Experimental Medication For the Treatment of Generalized Anxiety Disorder |
| Official title | A Double-Blind, Placebo Controlled Trial of an Experimental Medication For the Treatment of Generalized Anxiety Disorder |
| Lead sponsor | Jazz Pharmaceuticals, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Anxiety Disorder |
| Intervention type | Drug |
| Interventions | experimental anti-anxiety drug |
| Enrollment | 511 |
| Start date | Nov 1, 2004 |
| Completion | Dec 1, 2005 |
| First posted | Nov 30, 2004 |
| Last update posted | Oct 3, 2014 |
| Countries | United States |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: